|
The document discusses a draft exposure data gaps discussion on PFOA, developed by the EPA at the request of the Fluoropolymer Manufacturing Group and the Telomer Research Program, highlighting concerns about PFOA risks based on human blood monitoring data and suggesting the need for a detailed lifecycle assessment of commercial activities related to PFOA.
|
2002 |
AR226-1120
|
pmLxx8YejmJEY3kQKgL9YXGMX |
4 |